United Kingdom

Chinese investors spark IP fears with plans for British chip firm

UK government called on to investigate as Chinese backer moves to take up board seats, but the time to worry about IP ownership may be past

Chinese investors spark IP fears with plans for British chip firm
3D printing and IP in a pandemic
3 Apr 2020

3D printing and IP in a pandemic

As the technology is increasingly being used to manufacture vital supplies a balance can be struck between protecting rights and helping the fight against covid-19

German constitutional court rules country's accession to the UPC illegal
20 Mar 2020

German constitutional court rules country's accession to the UPC illegal

Decision focuses on process not principle, but the political reality is that the project is - for now, at least - dead

Latest

View all
30 Mar 2020

UK Patent Attorney Firm of the Year: Kilburn & Strode LLP

Read more

30 Mar 2020

UK Trademark Firm of the Year: Stobbs IP Limited

Read more

30 Mar 2020

UK Patent Law Firm of the Year: Powell Gilbert

Read more

4 Mar 2020

The rocky road ahead – 2020 Patent 100 reveals fall in applications

Despite a startling drop in applications, this year’s IAM/ktMINE ranking shows that financial institutions are ramping up activity. Read more

Designs

View all
10 Aug 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that Read more

3 Jul 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market Read more

3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda Read more

20 Feb 2019

"4IR is all-encompassing" says Centrica IP chief ahead of IPBC Europe in Paris

Charles Clark, who has been with the energy multinational since 2016, talks strategy for a new industrial era in an exclusive interview with IAM in advance of the event, taking place at the end of March Read more

Finance

View all
3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda Read more

30 May 2019

$1 billion Keytruda deal illustrates value of royalty right sales for research institutes

Transformative agreement shows why niche investment model may appeal to cash-strapped life sciences innovators Read more

12 Oct 2017

The secondary market in patents: what went right, what went wrong and how to fix it

Background The modern patent ecosystem owes much to the great US innovators of the 19th century, who pioneered the use of intellectual property as a business tool. They fought infamous patent wars and created a secondary market in invention by… Read more

6 Jun 2016

IPBC Global 2016 gets underway with the growing threat of Brexit hanging over the patent market

The IAM editorial team is in Barcelona currently for this year’s IPBC Global, which gets underway today. We have we over 500 delegates in attendance, many of whom hold senior IP leadership positions inside some of the world’s biggest and most…

Read more

Frand/SEPS

View all
4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

9 Jan 2020

Conversant receives timely UK boost before Supreme Court has its say

Unwired Planet judge rules that ZTE and Huawei infringed two of the NPE’s patents while a third was ruled invalid Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

5 Dec 2019

InterDigital head – China mustn't become the dominant player in setting FRAND rates

Bill Merritt speaks exclusively to IAM after the company files London lawsuit against Huawei which, he claims, is "working hard to have Chinese courts set-up as a royalty-determining jurisdiction for the world” Read more

Law & Policy

View all
4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

3 Mar 2020

A UPC without the UK adds to life sciences concerns about the court

Leading IP professionals give their view on what the British government’s decision not to participate in the system means for pharma and biotech patent litigation in Europe Read more

29 Feb 2020

After the UK’s UPC "No", do not rule out EPC exit next

Boris Johnson’s government has made clear that the views and interests of the British IP community will not influence patent policy, so nothing is off the table Read more

27 Feb 2020

The UK will not be part of the UPC, government confirms to IAM

"Participating in a court that applies EU law and bound by the CJEU is inconsistent with our aims of becoming an independent self-governing nation," says spokesperson Read more

Litigation

View all
4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

3 Mar 2020

A UPC without the UK adds to life sciences concerns about the court

Leading IP professionals give their view on what the British government’s decision not to participate in the system means for pharma and biotech patent litigation in Europe Read more

29 Feb 2020

After the UK’s UPC "No", do not rule out EPC exit next

Boris Johnson’s government has made clear that the views and interests of the British IP community will not influence patent policy, so nothing is off the table Read more

27 Feb 2020

The UK will not be part of the UPC, government confirms to IAM

"Participating in a court that applies EU law and bound by the CJEU is inconsistent with our aims of becoming an independent self-governing nation," says spokesperson Read more

Market Developments

View all
3 Mar 2020

A UPC without the UK adds to life sciences concerns about the court

Leading IP professionals give their view on what the British government’s decision not to participate in the system means for pharma and biotech patent litigation in Europe Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

17 Dec 2019

We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions Read more

4 Dec 2019

What leaked US trade talks tell us about future of UK pharma IP

Secret government documents detailing pharma patent discussions between UK and US officials have stirred up a controversy in the run up to the British general election later this month Read more

Non-Practising Entities

View all
6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

9 Jan 2020

Conversant receives timely UK boost before Supreme Court has its say

Unwired Planet judge rules that ZTE and Huawei infringed two of the NPE’s patents while a third was ruled invalid Read more

17 Dec 2019

We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

Patent Pools

View all
4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

30 Aug 2019

IP market news highlights

Some of the major news stories carried on the IAM platform in June and July Read more

30 Nov 2018

Doing intellectual property the Dolby Labs way

For over half a century Dolby Labs has worked hard to ensure that the company’s IP strategy is always aligned with its overall business goals. Its success in doing this teaches valuable lessons. Read more

Patents Law

View all
4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

3 Mar 2020

A UPC without the UK adds to life sciences concerns about the court

Leading IP professionals give their view on what the British government’s decision not to participate in the system means for pharma and biotech patent litigation in Europe Read more

29 Feb 2020

After the UK’s UPC "No", do not rule out EPC exit next

Boris Johnson’s government has made clear that the views and interests of the British IP community will not influence patent policy, so nothing is off the table Read more

27 Feb 2020

The UK will not be part of the UPC, government confirms to IAM

"Participating in a court that applies EU law and bound by the CJEU is inconsistent with our aims of becoming an independent self-governing nation," says spokesperson Read more

Strategy

View all
3 Mar 2020

A UPC without the UK adds to life sciences concerns about the court

Leading IP professionals give their view on what the British government’s decision not to participate in the system means for pharma and biotech patent litigation in Europe Read more

26 Feb 2020

CJEU for the first time considers the lawfulness (or otherwise) of pay-for-delay patent settlements

Pharmaceutical manufacturers may now find that authorities across Europe increasingly scrutinise patent litigation settlements Read more

18 Feb 2020

UK Supreme Court case could have big impact on biotech IP strategies

A much-watched dispute over Regeneron transgenic mice patents will affect when and how life sciences innovators seek protection for their increasingly complex inventions Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

Technology Licensing

View all
6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

9 Jan 2020

Conversant receives timely UK boost before Supreme Court has its say

Unwired Planet judge rules that ZTE and Huawei infringed two of the NPE’s patents while a third was ruled invalid Read more

17 Dec 2019

We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

Trade Secrets

View all
18 Feb 2020

UK Supreme Court case could have big impact on biotech IP strategies

A much-watched dispute over Regeneron transgenic mice patents will affect when and how life sciences innovators seek protection for their increasingly complex inventions Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

16 Oct 2019

WIPO report: US patent filings dip for first time since 2009

The number of grants also drops while UK sees worrying fall in applications; but study has good news for EPO President Campinos Read more

Valuation

View all
6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

1 Nov 2019

Unwired Planet and Conversant decisions likely to stand, which leaves Huawei and ZTE with big calls to make

The justices hearing the much-watched UK Supreme Court FRAND licensing appeals did not seem disposed to reverse, but that may not be the end of the story Read more

25 Oct 2019

UK Supreme Court hands employee-inventor a dramatic £2 million victory

Judgment vindicates professor’s 20-year fight for share of Unilever licensing profit and looks set to reshape British law on employee compensation for inventions Read more

Find an expert